查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513632

全球哺乳動物細胞銀行市場：產業分析、規模、佔有率、成長、趨勢、預測，2024-2033 年

Mammalian Cell Banking Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 251 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

本報告提供了有關全球哺乳動物細胞銀行市場的綜合報告。它全面評估了關鍵市場動態，包括市場驅動因素、趨勢、機會和課題，並提供了有關市場結構的詳細見解。

重要見解

  • 哺乳動物細胞銀行市場規模（2024 年）：4.965 億美元
  • 預計市值（2033年）：16億美元
  • 全球市場成長率（2024-2033年複合年增長率）：13.9%

哺乳動物細胞銀行市場 - 報告範圍：

哺乳動物細胞庫在生物製藥和生物技術產業中發揮重要作用，為各種應用（包括藥物開發、疫苗生產和再生醫學）的細胞系提供穩定的儲存庫。該市場為製藥公司、學術機構、研究機構和合約研究組織 (CRO) 提供服務，提供包括細胞系表徵、儲存和分銷在內的廣泛服務。

市場成長動力：

全球哺乳動物細胞庫市場由幾個關鍵因素推動，包括對生物製藥的需求增加、對細胞療法的投資增加以及提高細胞系穩定性和生產力的生物技術的進步。慢性病的盛行率不斷上升以及對生物製品高效生產的需求進一步推動了市場的擴張。此外，冷凍保存技術和品質控制措施的創新透過確保儲存細胞系的完整性和活力，有助於市場擴張。

市場限制因素：

儘管成長前景廣闊，但哺乳動物細胞銀行市場面臨著監管合規性、細胞系採購的道德考慮以及長期儲存過程中保持細胞系真實性和純度的複雜性等課題。管理細胞銀行實踐的嚴格法規以及持續監控以防止污染的需要給市場參與者帶來了營運課題，影響了可擴展性和成本效率。

市場機會：

由於個人化醫療、細胞治療和幹細胞研究的新興應用，哺乳動物細胞庫市場提供了巨大的成長機會。將自動化和機器人技術整合到細胞銀行設施中，可提高營運效率並減少人為錯誤，從而優化細胞繫管理和儲存。此外，生物製藥公司、學術機構和 CRO 之間的策略聯盟將促進知識交流並加速細胞銀行技術的創新。

本報告解決的關鍵問題

  • 推動全球哺乳動物細胞銀行市場成長的關鍵因素是什麼？
  • 哪些應用和治療領域正在推動哺乳動物細胞庫服務的需求？
  • 科技進步如何改變哺乳動物細胞銀行市場的競爭格局？
  • 誰是哺乳動物細胞銀行市場的主要參與者？ 他們保持市場領先地位的策略是什麼？
  • 全球哺乳動物細胞銀行市場的新趨勢和未來前景是什麼？

目錄

第1章 內容提要

第2章 市場概況

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包容與排除

第三章 主要市場趨勢

  • 影響市場的主要趨勢
  • 發展/創新趨勢

第 4 章關鍵成功因素

  • 管道評估
  • 價值鏈分析
  • 各大廠商主要促銷策略
  • 監管狀況
  • PESTLE分析
  • 波特的分析

第5章 市場背景

  • 宏觀經濟因素
  • 預測變量 - 相關性和影響
  • 市場動態

第 6 章 COVID-19 危機 - 影響評估

  • COVID-19 與影響分析
    • 依細胞
    • 依用途
    • 依最終用戶
    • 依地區
  • 2024年市場情景

第七章全球哺乳動物細胞銀行市場需求金額或規模（百萬美元）分析

  • 2019-2023 年歷史市值（百萬美元）分析
  • 2024-2033 年當前和未來市場價值（百萬美元）預測
    • 同比增長趨勢分析
    • 絕對美元機會分析

第八章全球哺乳動物細胞銀行市場分析：依細胞分類

  • 簡介/主要發現
  • 2019-2023 年歷史市場規模（百萬美元）分析（依電池）
  • 當前和未來市場規模（百萬美元）分析和預測（依電池），2024-2033 年
    • CHO
    • BHK
    • NS0
    • YB2/0・P2/0
    • HEK293/衍生物
    • 海拉
  • 市場吸引力分析：依電池

第九章全球哺乳動物細胞銀行市場分析：依技術分類

  • 簡介/主要發現
  • 2019-2023 年歷史市場規模（百萬美元）分析（依技術）
  • 2024-2033 年當前和未來市場規模（百萬美元）分析和預測（依技術）
    • TEP
    • IEP
    • SEP
  • 市場吸引力分析：依技術分類

第10章全球哺乳動物細胞銀行市場分析：依應用分類

  • 簡介/主要發現
  • 2019-2023 年歷史市場規模（百萬美元）分析（依應用）
  • 2024-2033 年當前和未來市場規模（百萬美元）分析和預測（依應用）
    • 微型斷路器
    • W.C.B.
    • 結束時間
    • 研發CB
  • 市場吸引力分析：依應用分類

第十一章全球哺乳動物細胞銀行市場分析：依最終用戶

  • 簡介/主要發現
  • 2019-2023 年歷史市場規模（百萬美元）分析（依最終用戶）
  • 當前和未來市場規模（百萬美元）分析和預測（依最終用戶），2024-2033 年
    • 學術研究機構
    • 生物製藥公司
    • CRO
  • 市場吸引力分析：依最終用戶

第十二章全球哺乳動物細胞銀行市場分析：依地區

  • 簡介/主要發現
  • 2019-2023 年歷史市場規模（百萬美元）分析（依地區）
  • 2024-2033 年當前和未來市場規模（百萬美元）分析和預測（依地區）
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東/非洲
  • 市場吸引力分析：依地區

第十三章北美哺乳動物細胞銀行市場分析

第十四章拉丁美洲哺乳動物細胞銀行市場分析

第十五章歐洲哺乳動物細胞銀行市場分析

第十六章南亞哺乳動物細胞銀行市場分析

第十七章東亞哺乳動物細胞銀行市場分析

第十八章大洋洲哺乳動物細胞銀行市場分析

第十九章中東與非洲哺乳動物細胞銀行市場分析

第二十章市場結構分析

  • 依公司層級劃分的市場分析
  • 主要企業市場佔有率分析（%）
  • 市場存在分析

第21章 競爭分析

  • 比賽儀表板
  • 競爭標桿
  • 衝突詳情
    • Eurofins DiscoverX Corporation
    • Merck KGaA
    • Sartorius Stedim BioOutsource Limited.
    • Charles River Laboratories
    • Altogen Labs
    • Abzena Ltd
    • Northway Biotechpharma
    • Lonza Group Ltd
    • VIRUSURE
    • Selexis SA
    • Sigma-Aldrich
    • Takara Bio Inc

第22章 所使用的假設與縮寫詞

第23章 研究方法論

簡介目錄
Product Code: PMRREP31663

Persistence Market Research has recently released a comprehensive report on the worldwide market for mammalian cell banking. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Mammalian Cell Banking Market Size (2024E): USD 496.5 Million
  • Projected Market Value (2033F): USD 1600 Million
  • Global Market Growth Rate (CAGR 2024 to 2033): 13.9%

Mammalian Cell Banking Market - Report Scope:

Mammalian cell banking plays a crucial role in biopharmaceutical and biotechnology industries, providing a stable repository of cell lines for various applications, including drug development, vaccine production, and regenerative medicine. The market serves pharmaceutical companies, academic institutions, research laboratories, and contract research organizations (CROs), offering a range of services such as cell line characterization, storage, and distribution.

Market Growth Drivers:

The global mammalian cell banking market is driven by several key factors, including the increasing demand for biopharmaceuticals, rising investments in cell-based therapies, and advancements in biotechnology that enhance cell line stability and productivity. The growing prevalence of chronic diseases and the need for efficient production of biologics further propel market expansion. Moreover, technological innovations in cryopreservation techniques and quality control measures contribute to market growth by ensuring the integrity and viability of stored cell lines.

Market Restraints:

Despite promising growth prospects, the mammalian cell banking market faces challenges related to regulatory compliance, ethical considerations in cell line sourcing, and the complexity of maintaining cell line authenticity and purity over extended storage periods. Stringent regulations governing cell banking practices and the need for continuous monitoring to prevent contamination impose operational challenges on market players, affecting scalability and cost-efficiency.

Market Opportunities:

The mammalian cell banking market presents significant growth opportunities driven by emerging applications in personalized medicine, cell therapy, and stem cell research. The integration of automation and robotics in cell banking facilities enhances operational efficiency and reduces human error, thereby optimizing cell line management and storage. Furthermore, strategic collaborations between biopharmaceutical companies, academic institutions, and CROs facilitate knowledge exchange and accelerate innovation in cell banking technologies.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the mammalian cell banking market globally?
  • Which applications and therapeutic areas are driving demand for mammalian cell banking services?
  • How are technological advancements reshaping the competitive landscape of the mammalian cell banking market?
  • Who are the key players contributing to the mammalian cell banking market, and what strategies are they employing to maintain market leadership?
  • What are the emerging trends and future prospects in the global mammalian cell banking market?

Competitive Intelligence and Business Strategy:

Leading players in the global mammalian cell banking market, including Merck KGaA, Altogen Labs, and VIRUSURE, focus on innovation, expansion of service portfolios, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced cell banking solutions, including automated cryopreservation systems, cell line authentication technologies, and personalized medicine applications. Collaborations with regulatory agencies and industry stakeholders promote compliance with international quality standards and facilitate market access.

Key Companies Profiled:

  • Eurofins DiscoverX Corporation
  • Merck KGaA
  • Sartorius Stedim BioOutsource Limited.
  • Charles River Laboratories
  • Altogen Labs
  • Abzena Ltd
  • Northway Biotechpharma
  • Lonza Group Ltd
  • VIRUSURE
  • Selexis SA
  • Takara Bio Inc

Key Segments Covered in Manufacturing of Industry Research

Cell Type:

  • CHO
  • BHK
  • NS0
  • YB2/0 & P2/0
  • HEK293 & Derivatives
  • HELA

Technology:

  • TEP
  • IEP
  • SEP

Application:

  • MCB
  • WCB
  • EoP
  • R&D CB

End User:

  • Academic & Research Institute
  • Biopharmaceutical Companies
  • CROs

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Development/Innovation Trends

4. Key Success Factors

  • 4.1. Pipeline Assessment
  • 4.2. Value chain Analysis
  • 4.3. Key Promotional Strategies, By Key Manufacturers
  • 4.4. Regulatory Landscape
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Global Cell Banking Outsourcing Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Key Player's Historic Growth
    • 5.2.2. Market Consolidation Activities
    • 5.2.3. Increasing Geriatric Population
    • 5.2.4. Rising Cases of Cancer
    • 5.2.5. Growing Preference of Mammalian Cell Banking
    • 5.2.6. Increased R&D investments by Government
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Cell
    • 6.1.2. By Technology
    • 6.1.3. By Application
    • 6.1.4. By End User
    • 6.1.5. By Region
  • 6.2. 2024 Market Scenario

7. Global Mammalian Cell Banking Market Demand Value or Size in (US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Cell

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Cell, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cell, 2024-2033
    • 8.3.1. CHO
    • 8.3.2. BHK
    • 8.3.3. NS0
    • 8.3.4. YB2/0 & P2/0
    • 8.3.5. HEK293 & Derivatives
    • 8.3.6. HELA
  • 8.4. Market Attractiveness Analysis By Cell

9. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Technology

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) By Technology, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2024-2033
    • 9.3.1. TEP
    • 9.3.2. IEP
    • 9.3.3. SEP
  • 9.4. Market Attractiveness Analysis By Technology

10. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2033
    • 10.3.1. MCB
    • 10.3.2. WCB
    • 10.3.3. EoP
    • 10.3.4. R&D CB
  • 10.4. Market Attractiveness Analysis By Application

11. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
    • 11.3.1. Academic & Research Institute
    • 11.3.2. Biopharmaceutical Companies
    • 11.3.3. CROs
  • 11.4. Market Attractiveness Analysis By End User

12. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2023
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Cell
    • 13.3.3. By Technology
    • 13.3.4. By Application
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Cell
    • 13.4.3. By Technology
    • 13.4.4. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Mammalian Cell Banking Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Cell
        • 13.8.1.2.2. By Technology
        • 13.8.1.2.3. By Application
        • 13.8.1.2.4. By End User
    • 13.8.2. Canada Mammalian Cell Banking Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Cell
        • 13.8.2.2.2. By Technology
        • 13.8.2.2.3. By Application
        • 13.8.2.2.4. By End User

14. Latin America Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Cell
    • 14.3.3. By Technology
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Cell
    • 14.4.3. By Technology
    • 14.4.4. By Application
    • 14.4.5. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico Mammalian Cell Banking Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Cell
        • 14.8.1.2.2. By Technology
        • 14.8.1.2.3. By Application
        • 14.8.1.2.4. By End User
    • 14.8.2. Brazil Mammalian Cell Banking Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Cell
        • 14.8.2.2.2. By Technology
        • 14.8.2.2.3. By Application
        • 14.8.2.2.4. By End User
    • 14.8.3. Argentina Mammalian Cell Banking Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Cell
        • 14.8.3.2.2. By Technology
        • 14.8.3.2.3. By Application
        • 14.8.3.2.4. By End User

15. Europe Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Italy
      • 15.3.1.2. Germany
      • 15.3.1.3. U.K
      • 15.3.1.4. France
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Nordic Countries
      • 15.3.1.8. Russia
      • 15.3.1.9. Rest of Europe
    • 15.3.2. By Cell
    • 15.3.3. By Technology
    • 15.3.4. By Application
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Cell
    • 15.4.3. By Technology
    • 15.4.4. By Application
    • 15.4.5. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Italy Mammalian Cell Banking Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Cell
        • 15.8.1.2.2. By Technology
        • 15.8.1.2.3. By Application
        • 15.8.1.2.4. By End User
    • 15.8.2. Germany Mammalian Cell Banking Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Cell
        • 15.8.2.2.2. By Technology
        • 15.8.2.2.3. By Application
        • 15.8.2.2.4. By End User
    • 15.8.3. U.K. Mammalian Cell Banking Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Cell
        • 15.8.3.2.2. By Technology
        • 15.8.3.2.3. By Application
        • 15.8.3.2.4. By End User
    • 15.8.4. France Mammalian Cell Banking Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Cell
        • 15.8.4.2.2. By Technology
        • 15.8.4.2.3. By Application
        • 15.8.4.2.4. By End User
    • 15.8.5. Spain Mammalian Cell Banking Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Cell
        • 15.8.5.2.2. By Technology
        • 15.8.5.2.3. By Application
        • 15.8.5.2.4. By End User
    • 15.8.6. BENELUX Mammalian Cell Banking Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Cell
        • 15.8.6.2.2. By Technology
        • 15.8.6.2.3. By Application
        • 15.8.6.2.4. By End User
    • 15.8.7. Nordic Countries Mammalian Cell Banking Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Cell
        • 15.8.7.2.2. By Technology
        • 15.8.7.2.3. By Application
        • 15.8.7.2.4. By End User
    • 15.8.8. Russia Mammalian Cell Banking Market Analysis
      • 15.8.8.1. Introduction
      • 15.8.8.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.8.2.1. By Cell
        • 15.8.8.2.2. By Technology
        • 15.8.8.2.3. By Application
        • 15.8.8.2.4. By End User

16. South Asia Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Cell
    • 16.3.3. By Technology
    • 16.3.4. By Application
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Cell
    • 16.4.3. By Technology
    • 16.4.4. By Application
    • 16.4.5. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Mammalian Cell Banking Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Cell
        • 16.8.1.2.2. By Technology
        • 16.8.1.2.3. By Application
        • 16.8.1.2.4. By End User
    • 16.8.2. Indonesia Mammalian Cell Banking Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Cell
        • 16.8.2.2.2. By Technology
        • 16.8.2.2.3. By Application
        • 16.8.2.2.4. By End User
    • 16.8.3. Malaysia Mammalian Cell Banking Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Cell
        • 16.8.3.2.2. By Technology
        • 16.8.3.2.3. By Application
        • 16.8.3.2.4. By End User
    • 16.8.4. Thailand Mammalian Cell Banking Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Cell
        • 16.8.4.2.2. By Technology
        • 16.8.4.2.3. By Application
        • 16.8.4.2.4. By End User

17. East Asia Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Cell
    • 17.3.3. By Technology
    • 17.3.4. By Application
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Cell
    • 17.4.3. By Technology
    • 17.4.4. By Application
    • 17.4.5. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. China Mammalian Cell Banking Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Cell
        • 17.8.1.2.2. By Technology
        • 17.8.1.2.3. By Application
        • 17.8.1.2.4. By End User
    • 17.8.2. Japan Mammalian Cell Banking Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Cell
        • 17.8.2.2.2. By Technology
        • 17.8.2.2.3. By Application
        • 17.8.2.2.4. By End User
    • 17.8.3. South Korea Mammalian Cell Banking Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Cell
        • 17.8.3.2.2. By Technology
        • 17.8.3.2.3. By Application
        • 17.8.3.2.4. By End User

18. Oceania Mammalian Cell Banking Market 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Cell
    • 18.3.3. By Technology
    • 18.3.4. By Application
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Cell
    • 18.4.3. By Technology
    • 18.4.4. By Application
    • 18.4.5. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Mammalian Cell Banking Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Cell
        • 18.8.1.2.2. By Technology
        • 18.8.1.2.3. By Application
        • 18.8.1.2.4. By End User
    • 18.8.2. New Zealand Mammalian Cell Banking Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Cell
        • 18.8.2.2.2. By Technology
        • 18.8.2.2.3. By Application
        • 18.8.2.2.4. By End User

19. Middle East and Africa (MEA) Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkey
      • 19.3.1.3. South Africa
      • 19.3.1.4. North Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Cell
    • 19.3.3. By Technology
    • 19.3.4. By Application
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Cell
    • 19.4.3. By Technology
    • 19.4.4. By Application
    • 19.4.5. By End User
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Mammalian Cell Banking Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Cell
        • 19.8.1.2.2. By Technology
        • 19.8.1.2.3. By Application
        • 19.8.1.2.4. By End User
    • 19.8.2. Turkey Mammalian Cell Banking Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Cell
        • 19.8.2.2.2. By Technology
        • 19.8.2.2.3. By Application
        • 19.8.2.2.4. By End User
    • 19.8.3. South Africa Mammalian Cell Banking Market Analysis
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Cell
        • 19.8.3.2.2. By Technology
        • 19.8.3.2.3. By Application
        • 19.8.3.2.4. By End User
    • 19.8.4. North Africa Mammalian Cell Banking Market Analysis
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Cell
        • 19.8.4.2.2. By Technology
        • 19.8.4.2.3. By Application
        • 19.8.4.2.4. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players (%)
  • 20.3. Market Presence Analysis
    • 20.3.1. By Regional Footprint of Players
    • 20.3.2. Cell Footprint of Players
    • 20.3.3. Channel Footprint of Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Eurofins DiscoverX Corporation
      • 21.3.1.1. Overview
      • 21.3.1.2. Product & Services Portfolio
      • 21.3.1.3. Key Financials
      • 21.3.1.4. SWOT Analysis
      • 21.3.1.5. Key Developments
      • 21.3.1.6. Sales Footprint
      • 21.3.1.7. Strategy Overview
        • 21.3.1.7.1. Marketing Strategy
        • 21.3.1.7.2. Product Strategy
        • 21.3.1.7.3. Channel Strategy
    • 21.3.2. Merck KGaA
      • 21.3.2.1. Overview
      • 21.3.2.2. Product & Services Portfolio
      • 21.3.2.3. Key Financials
      • 21.3.2.4. SWOT Analysis
      • 21.3.2.5. Key Developments
      • 21.3.2.6. Sales Footprint
      • 21.3.2.7. Strategy Overview
        • 21.3.2.7.1. Marketing Strategy
        • 21.3.2.7.2. Product Strategy
        • 21.3.2.7.3. Channel Strategy
    • 21.3.3. Sartorius Stedim BioOutsource Limited.
      • 21.3.3.1. Overview
      • 21.3.3.2. Product & Services Portfolio
      • 21.3.3.3. Key Financials
      • 21.3.3.4. SWOT Analysis
      • 21.3.3.5. Key Developments
      • 21.3.3.6. Sales Footprint
      • 21.3.3.7. Strategy Overview
        • 21.3.3.7.1. Marketing Strategy
        • 21.3.3.7.2. Product Strategy
        • 21.3.3.7.3. Channel Strategy
    • 21.3.4. Charles River Laboratories
      • 21.3.4.1. Overview
      • 21.3.4.2. Product & Services Portfolio
      • 21.3.4.3. Key Financials
      • 21.3.4.4. SWOT Analysis
      • 21.3.4.5. Key Developments
      • 21.3.4.6. Sales Footprint
      • 21.3.4.7. Strategy Overview
        • 21.3.4.7.1. Marketing Strategy
        • 21.3.4.7.2. Product Strategy
        • 21.3.4.7.3. Channel Strategy
    • 21.3.5. Altogen Labs
      • 21.3.5.1. Overview
      • 21.3.5.2. Product & Services Portfolio
      • 21.3.5.3. Key Financials
      • 21.3.5.4. SWOT Analysis
      • 21.3.5.5. Key Developments
      • 21.3.5.6. Sales Footprint
      • 21.3.5.7. Strategy Overview
        • 21.3.5.7.1. Marketing Strategy
        • 21.3.5.7.2. Product Strategy
        • 21.3.5.7.3. Channel Strategy
    • 21.3.6. Abzena Ltd
      • 21.3.6.1. Overview
      • 21.3.6.2. Product & Services Portfolio
      • 21.3.6.3. Key Financials
      • 21.3.6.4. SWOT Analysis
      • 21.3.6.5. Key Developments
      • 21.3.6.6. Sales Footprint
      • 21.3.6.7. Strategy Overview
        • 21.3.6.7.1. Marketing Strategy
        • 21.3.6.7.2. Product Strategy
        • 21.3.6.7.3. Channel Strategy
    • 21.3.7. Northway Biotechpharma
      • 21.3.7.1. Overview
      • 21.3.7.2. Product & Services Portfolio
      • 21.3.7.3. Key Financials
      • 21.3.7.4. SWOT Analysis
      • 21.3.7.5. Key Developments
      • 21.3.7.6. Sales Footprint
      • 21.3.7.7. Strategy Overview
        • 21.3.7.7.1. Marketing Strategy
        • 21.3.7.7.2. Product Strategy
        • 21.3.7.7.3. Channel Strategy
    • 21.3.8. Lonza Group Ltd
      • 21.3.8.1. Overview
      • 21.3.8.2. Product & Services Portfolio
      • 21.3.8.3. Key Financials
      • 21.3.8.4. SWOT Analysis
      • 21.3.8.5. Key Developments
      • 21.3.8.6. Sales Footprint
      • 21.3.8.7. Strategy Overview
        • 21.3.8.7.1. Marketing Strategy
        • 21.3.8.7.2. Product Strategy
        • 21.3.8.7.3. Channel Strategy
    • 21.3.9. VIRUSURE
      • 21.3.9.1. Overview
      • 21.3.9.2. Product & Services Portfolio
      • 21.3.9.3. Key Financials
      • 21.3.9.4. SWOT Analysis
      • 21.3.9.5. Key Developments
      • 21.3.9.6. Sales Footprint
      • 21.3.9.7. Strategy Overview
        • 21.3.9.7.1. Marketing Strategy
        • 21.3.9.7.2. Product Strategy
        • 21.3.9.7.3. Channel Strategy
    • 21.3.10. Selexis SA
      • 21.3.10.1. Overview
      • 21.3.10.2. Product & Services Portfolio
      • 21.3.10.3. Key Financials
      • 21.3.10.4. SWOT Analysis
      • 21.3.10.5. Key Developments
      • 21.3.10.6. Sales Footprint
      • 21.3.10.7. Strategy Overview
        • 21.3.10.7.1. Marketing Strategy
        • 21.3.10.7.2. Product Strategy
        • 21.3.10.7.3. Channel Strategy
    • 21.3.11. Sigma-Aldrich
      • 21.3.11.1. Overview
      • 21.3.11.2. Product & Services Portfolio
      • 21.3.11.3. Key Financials
      • 21.3.11.4. SWOT Analysis
      • 21.3.11.5. Key Developments
      • 21.3.11.6. Sales Footprint
      • 21.3.11.7. Strategy Overview
        • 21.3.11.7.1. Marketing Strategy
        • 21.3.11.7.2. Product Strategy
        • 21.3.11.7.3. Channel Strategy
    • 21.3.12. Takara Bio Inc
      • 21.3.12.1. Overview
      • 21.3.12.2. Product & Services Portfolio
      • 21.3.12.3. Key Financials
      • 21.3.12.4. SWOT Analysis
      • 21.3.12.5. Key Developments
      • 21.3.12.6. Sales Footprint
      • 21.3.12.7. Strategy Overview
        • 21.3.12.7.1. Marketing Strategy
        • 21.3.12.7.2. Product Strategy
        • 21.3.12.7.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology